FDA Approved Pediatric Antihypertensive Agents

The document reviewed the considerations for selecting long-term antihypertensive agents in pediatric patients, emphasizing the importance of understanding FDA-approved medications and their trials in children. It discussed factors such as co-morbid conditions, side effects, liquid preparation availability, dosing intervals, and costs. The review covered major medication classes, their mechanisms, representative agents approved for children, and highlighted common side effects, contraindications, and suitable patient populations. It also noted that while FDA approval is important, it should not restrict the use of non-approved agents in children when necessary.